CN101357922A - 新的dpp-iv抑制剂 - Google Patents
新的dpp-iv抑制剂 Download PDFInfo
- Publication number
- CN101357922A CN101357922A CN 200810145064 CN200810145064A CN101357922A CN 101357922 A CN101357922 A CN 101357922A CN 200810145064 CN200810145064 CN 200810145064 CN 200810145064 A CN200810145064 A CN 200810145064A CN 101357922 A CN101357922 A CN 101357922A
- Authority
- CN
- China
- Prior art keywords
- alkyl group
- low alkyl
- represent hydrogen
- hydrogen atom
- trifluoromethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008101450645A CN101357922B (zh) | 2007-08-02 | 2008-07-31 | 新的dpp-iv抑制剂 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200710016737.2 | 2007-08-02 | ||
CN200710016737 | 2007-08-02 | ||
CN2008101450645A CN101357922B (zh) | 2007-08-02 | 2008-07-31 | 新的dpp-iv抑制剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101357922A true CN101357922A (zh) | 2009-02-04 |
CN101357922B CN101357922B (zh) | 2011-05-18 |
Family
ID=40330535
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2008101450645A Active CN101357922B (zh) | 2007-08-02 | 2008-07-31 | 新的dpp-iv抑制剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101357922B (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101899047A (zh) * | 2009-05-26 | 2010-12-01 | 北京翔宇恒天医药技术有限公司 | 作为二肽基肽酶抑制剂用于治疗或预防糖尿病的β-氨基四氢吡嗪、四氢嘧啶和四氢吡啶 |
CN102600161A (zh) * | 2011-12-19 | 2012-07-25 | 武汉大学 | 磷酸西他列汀在制备防治热性惊厥药物中的应用 |
CN103201260A (zh) * | 2010-11-11 | 2013-07-10 | 莱德克斯制药有限公司 | 药物衍生物 |
US9469645B2 (en) | 2009-07-09 | 2016-10-18 | Novartis Ag | Compounds and compositions for the treatment of parasitic diseases |
US10894794B1 (en) * | 2019-12-18 | 2021-01-19 | King Abdulaziz University | Substituted [1,2,4]triazolo[4,3-a]pyrazines as antidiabetics |
US11738028B2 (en) | 2017-04-24 | 2023-08-29 | Novartis Ag | Therapeutic regimen |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JO2625B1 (en) * | 2003-06-24 | 2011-11-01 | ميرك شارب اند دوم كوربوريشن | Phosphoric acid salts of dipeptidyl betidase inhibitor 4 |
AU2005219508B2 (en) * | 2004-02-18 | 2012-02-16 | Boehringer Ingelheim International Gmbh | 8-[3-amino-piperidin-1-yl]-xanthine, the production thereof and the use in the form of a DPP inhibitor |
TWI357902B (en) * | 2005-04-01 | 2012-02-11 | Lg Life Science Ltd | Dipeptidyl peptidase-iv inhibiting compounds, meth |
-
2008
- 2008-07-31 CN CN2008101450645A patent/CN101357922B/zh active Active
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101899047A (zh) * | 2009-05-26 | 2010-12-01 | 北京翔宇恒天医药技术有限公司 | 作为二肽基肽酶抑制剂用于治疗或预防糖尿病的β-氨基四氢吡嗪、四氢嘧啶和四氢吡啶 |
CN101899047B (zh) * | 2009-05-26 | 2016-01-20 | 盛世泰科生物医药技术(苏州)有限公司 | 作为二肽基肽酶抑制剂用于治疗或预防糖尿病的β-氨基四氢吡嗪、四氢嘧啶和四氢吡啶 |
US9469645B2 (en) | 2009-07-09 | 2016-10-18 | Novartis Ag | Compounds and compositions for the treatment of parasitic diseases |
CN103201260A (zh) * | 2010-11-11 | 2013-07-10 | 莱德克斯制药有限公司 | 药物衍生物 |
CN103201260B (zh) * | 2010-11-11 | 2015-05-27 | 莱德克斯制药有限公司 | 药物衍生物 |
CN102600161A (zh) * | 2011-12-19 | 2012-07-25 | 武汉大学 | 磷酸西他列汀在制备防治热性惊厥药物中的应用 |
CN102600161B (zh) * | 2011-12-19 | 2013-04-24 | 武汉大学 | 磷酸西他列汀在制备防治热性惊厥药物中的应用 |
US11738028B2 (en) | 2017-04-24 | 2023-08-29 | Novartis Ag | Therapeutic regimen |
US10894794B1 (en) * | 2019-12-18 | 2021-01-19 | King Abdulaziz University | Substituted [1,2,4]triazolo[4,3-a]pyrazines as antidiabetics |
Also Published As
Publication number | Publication date |
---|---|
CN101357922B (zh) | 2011-05-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101357922B (zh) | 新的dpp-iv抑制剂 | |
NZ516616A (en) | Beta-carboline pharmaceutical compositions | |
CN102127070A (zh) | 吡啶并环衍生物 | |
CN1278175A (zh) | 降脂剂的组合物 | |
CN101357921B (zh) | 新的二肽酶-iv抑制剂化合物 | |
CN101418000B (zh) | 含有苯并呋喃磺酰脲的dpp-iv抑制剂衍生物 | |
CN101397300B (zh) | 二肽酶-ⅳ抑制剂衍生物 | |
CN101357923B (zh) | 二肽酶抑制剂化合物 | |
CN101357924B (zh) | 二肽酶-iv抑制剂化合物 | |
CN101418001B (zh) | 二肽酶-iv抑制剂磺酰脲衍生物 | |
CN102153538B (zh) | 苯并环衍生物 | |
CN101723947B (zh) | 二肽酶-ⅳ抑制剂化合物 | |
CN101781274B (zh) | 酰化哌嗪类二肽酰肽酶ⅳ抑制剂 | |
MX2010014524A (es) | Formulaciones de dosificacion solida de telcagepant potásico. | |
CN101486689B (zh) | 具有磺酰胺基甲酰胺哌嗪结构的dpp-iv抑制剂 | |
CN1764381A (zh) | 用于酪氨酸激酶抑制剂的制剂 | |
CN101417987B (zh) | 具有磺酰胺甲酰哌嗪结构的dpp-iv抑制剂 | |
CN101417988B (zh) | 双胍哌嗪类二肽酰肽酶ⅳ抑制剂 | |
CN102234281B (zh) | 嘧啶并环衍生物 | |
CN101781273B (zh) | 含有胍基的二肽酰肽酶ⅳ抑制剂 | |
CN101550139A (zh) | 含有三唑并吡嗪的二肽酶-iv抑制剂 | |
CN102304088A (zh) | 一种伊伐布雷定化合物、制备方法及其药物组合物 | |
CN101404981A (zh) | 治疗舒张性心力衰竭的方法和组合物 | |
CN101497605B (zh) | 含有被烷氧基取代的吡啶的苯并咪唑衍生物 | |
CN101486688A (zh) | 具有磺酰基胺酰烷基哌嗪结构的dpp-iv抑制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: BEIJING AOHE PHARMACEUTICAL RESEARCH INSTITUTE CO. Free format text: FORMER OWNER: SHANDONG XUANZHU MEDICAL TECHNOLOGY CO., LTD. Effective date: 20130407 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 250101 JINAN, SHANDONG PROVINCE TO: 100043 SHIJINGSHAN, BEIJING |
|
TR01 | Transfer of patent right |
Effective date of registration: 20130407 Address after: 100043, A, block 33, three ancient West Street, Shijingshan District, Beijing Patentee after: Beijing Aohe Pharmaceutical Research Institute Co., Ltd. Address before: Tianchen Avenue in Ji'nan high tech Development Zone of Shandong province 250101 City No. 2518 Patentee before: Shandong Xuanzhu Medical Technology Co., Ltd. |
|
DD01 | Delivery of document by public notice |
Addressee: Huang Xiaoxia Document name: Notification of Passing Examination on Formalities |